Entering text into the input field will update the search result below

DermTech, Inc. (DMTK) CEO John Dobak on Q1 2022 Results - Earnings Call Transcript

May 03, 2022 8:57 PM ETDermTech, Inc. (DMTK)
SA Transcripts profile picture
SA Transcripts

DermTech, Inc. (NASDAQ:DMTK) Q1 2022 Earnings Conference Call March 3, 2022 5:00 PM ET

Company Participants

John Dobak – President and Chief Executive Officer

Kevin Sun – Chief Financial Officer

Steve Kunszabo – Senior Director Investor Relations

Conference Call Participants

Brian Weinstein – William Blair

Stephanie Iannetta – Cowen & Company

Alexander Nowak – Craig-Hallum Capital

Thomas Flaten – Lake Street Capital Markets

Jacob Johnson – Stephens Inc.


Good day, and thank you for standing by. And welcome to DermTech's First Quarter 2022 Financial Results Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a questions and answer session. [Operator Instructions] I will now hand the call over to Mr. Steve Kunszabo.

Steve Kunszabo

Thank you. Operator. Welcome to DermTech's First Quarter 2022 Earnings Call. Joining me on the call today are Dr. John Dobak, our President and Chief Executive Officer, and Kevin Sun, our Chief Financial Officer. Our call today will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements made on this call that do not relate to matters of historical fact are considered forward-looking statements.

Forward-looking statements made during this call, including projections of future performance are based on management expectations as of today and are subject to various factors, assumptions, risks, and uncertainties, which change over time. Actual results could differ materially from those described in such statements. Several factors that may contribute to or cause such differences are described in today's press release and our most recent filings with the SEC including our annual report on Form 10-K for the year ended December 31st, 2021 and our quarterly report on Form 10-Q for the quarter ended March 31st, 2022.

We undertake no obligation to update these statements

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.